probenecid has been researched along with ginsenosides in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, NH; Heng, Y; Hu, JF; Mu, Z; Yuan, YH; Zhang, QS | 1 |
1 other study(ies) available for probenecid and ginsenosides
Article | Year |
---|---|
Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Ginsenosides; Inflammation; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Parkinson Disease; Parkinsonian Disorders; Probenecid; Substantia Nigra; Tumor Necrosis Factor-alpha | 2016 |